Related Experiment Video
Updated: May 3, 2026

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer
Published on: March 17, 2016
SUPT6H controls estrogen receptor activity and cellular differentiation by multiple epigenomic mechanisms
U Bedi1, A H Scheel2, M Hennion3
11] Center of Experimental Medicine, Department of Tumor Biology, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany [2] Institute of Molecular Oncology, University Medical Center Göttingen, Göttingen, Germany.
Suppressor of Ty Homologue-6 (SUPT6H) is crucial for estrogen-regulated transcription and breast cancer cell differentiation. Its decreased levels correlate with malignancy, identifying SUPT6H as a potential therapeutic target in hormone-resistant breast cancer.
Area of Science:
- Epigenetics
- Molecular Biology
- Cancer Research
Background:
- Estrogen receptor alpha (ERα) drives ductal mammary epithelial development and is a key prognostic marker in breast cancer.
- Antiestrogen therapies are initially effective but often lead to hormone-resistant, poorly differentiated tumors with reduced survival.
- Understanding molecular mechanisms of resistance is vital for identifying new therapeutic targets and predictive markers.
Purpose of the Study:
- To investigate the role of the histone chaperone SUPT6H in ERα activity and breast cancer progression.
- To explore the relationship between SUPT6H, transcriptional elongation, chromatin structure, and ERα-dependent gene expression.
- To determine the clinical relevance of SUPT6H levels in breast cancer malignancy.
Main Methods:
- Investigated SUPT6H function in estrogen-regulated transcription and chromatin maintenance in breast cancer cells.
- Examined potential interactions between SUPT6H, RNF40, and histone H2B monoubiquitination (H2Bub1).
- Assessed SUPT6H protein levels in relation to breast cancer malignancy and its role in cellular differentiation and epigenetic modifications (H3K27me3).
Main Results:
- SUPT6H is essential for estrogen-regulated transcription and maintaining chromatin structure in breast cancer cells.
- SUPT6H interacts with RNF40 and influences H2Bub1 levels.
- SUPT6H protein levels decrease with increasing breast cancer malignancy.
- SUPT6H is required for cellular differentiation and suppressing the repressive H3K27me3 mark on lineage-specific genes.
Conclusions:
- SUPT6H acts as a critical epigenetic regulator of ERα activity and cellular differentiation in breast cancer.
- SUPT6H's role in maintaining chromatin structure and promoting differentiation suggests its potential as a therapeutic target.
- Reduced SUPT6H levels indicate a link to malignancy and could serve as a predictive marker for treatment resistance.
Related Concept Videos
Target Cell Response to Hormones
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Epigenetic Regulation
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Master Transcription Regulators

